Campylobacter jejuni (C. jejuni) is one of the most important zoonotic pathogens worldwide. In Europe, the majority of the cases are caused by consuming contaminated poultry meat. The objective of the present study was to investigate potential effects of different crude protein levels in complete diets for broilers on infection dynamics of C. jejuni after experimental infection. In total, 300 commercial broilers line Ross 308 were divided into 4 different groups, including 5 replications of 15 chickens each. The chickens were fed a conventional diet (212 g CP/kg DM) and a protein-reduced test diet (190 g CP/kg DM) supplemented with essential amino acids. This resulted simultaneously in lower amino-acid concentrations preferentially utilized by C. jejuni, such as aspartate, glutamate, proline, and serine. One group of each feeding concept was infected artificially with C. jejuni at day 21 by applying an oral C. jejuni inoculum containing 4.17 ± 0.09 log10 cfu of C. jejuni to 3 of 15 chickens, called “seeders.” Feeding the test diet resulted in a significant reduction (P < 0.001) in CP intake (31.5 ± 1.20 g CP/broiler/day and 27.7 ± 0.71 g CP/broiler/day, respectively), a significant decrease (P < 0.05) in crude mucin in excreta (55.7 ± 8.23 g/kg DM and 51.9 ± 7.62 g/kg DM, respectively), and in goblet cell number in cecal crypts (P < 0.05; 15.1 ± 5.71 vs. 13.6 ± 5.91 goblet cells/crypt). In groups receiving the test diet, the excretion of C. jejuni was significantly reduced in seeders by 1.9 log10 cfu/g excreta at day 23 (3.38a ± 2.55 vs. 1.47b ± 2.20; P = 0.033). At day 25, prevalence of C. jejuni in cloacal swabs amounted to 53.3% in the group fed the test diet and 75.7% in the control group, respectively (P < 0.05). In summary, a definite amino acid pattern in the broiler diets could contribute to a development of an effective feeding strategy to reduce the prevalence of C. jejuni infection in chickens (Patent No 17187659.2-1106).
In 2016, Campylobacter was the most commonly reported gastrointestinal bacterial pathogen in humans in the European Union with 246,307 reported cases. Of these cases, 83.6% were Campylobacter jejuni. The objective of the present study was to investigate to what extent an infection with C. jejuni alters the feed intake behavior of broiler chicks in terms of protein intake. This was done to see if, conversely, measures of control could be derived. In total, 300 commercial broilers of the Ross 308 line were allocated to four different groups, including five replications of 15 chickens each. In two groups, a conventional diet [216 g CP/kg dry matter (DM)] and in the two choice diet groups, diets with different levels of crude protein (286 and 109 g CP/kg DM, respectively) were fed between day 14 and day 42. An intake of both choice diets at a ratio of 3:2 resulted in a composition of consumed feed identical to that of the control concerning composition, energy and nutrient content. One group of each feeding concept was infected artificially with C. jejuni at day 21 by applying an oral C. jejuni-suspension containing 5.26 ± 0.08 log10 colony forming units of C. jejuni to three out of 15 chickens. No significant differences concerning C. jejuni prevalence and excretion could be seen. Broilers infected with C. jejuni chose a higher amount of the high protein choice diet in comparison to C. jejuni negative broilers. This resulted in a significantly (p < 0.0001) higher content of crude protein in the consumed diet (198 ± 3.09 g CP/kg DM and 208 ± 8.57 g CP/kg DM, respectively). Due to C. jejuni infection, a significant increase in crude mucin in excreta at day 42 was seen in experimentally infected groups (62.6 ± 4.62 g/kg DM vs. 59.6 ± 6.21 g/kg DM, respectively; p = 0.0396). There were significantly deeper crypts in infected birds (256 ± 71.6 vs. 234 ± 61.3 μm). In summary, C. jejuni infections significantly alter the feed intake behavior of broiler chickens regarding higher protein intake. Therefore, targeted manipulation of protein supply could be tested for limiting the spread of infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.